HI
CODX

Harbour Investments’s Co-Diagnostics CODX Stock Holding History

Harbour Investments’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6 Hold
2
– – ﹤0.01% 4748
2026
Q1 		$4 Buy
+2
New +$7 ﹤0.01% 4653
2024
Q1 		– Hold
0
– -$13 – 3230
2023
Q4 		– Hold
0
– – – 3113
2023
Q3 		– Hold
0
– – – 2976
2023
Q2 		– Hold
0
– – – 3010
2023
Q1 		– Hold
0
– – – 2980
2022
Q4 		– Hold
0
– – – 2973
2022
Q3 		– Hold
0
– – – 2735
2022
Q2 		– Hold
0
– – – 2735
2021
Q4 		– Sell
-17
Closed -$4.46K – 2818
2021
Q3 		$5K Hold
17
– – ﹤0.01% 2966
2021
Q2 		$4K Hold
17
– – ﹤0.01% 3127
2021
Q1 		$5K Buy
+17
New +$6.79K ﹤0.01% 2891

Other funds holding CODX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAG
Private Advisory Group Redmond, Washington $1.85B AUM 50.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Harbour Investments's CODX Position: Q2 2026 in Review

Harbour Investments held its Co-Diagnostics (CODX) position steady in Q2 2026 at 2 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #4748.

Harbour Investments first reported a position in CODX in Q1 2021 and has held it in 5 quarters since. The position peaked at $5K in Q3 2021. 24 funds tracked by Wall St. Rank hold CODX as of Q2 2026.

  • Harbour Investments held 2 shares of Co-Diagnostics worth $6 as of Q2 2026.
  • Harbour Investments left its Co-Diagnostics share count unchanged in Q2 2026.
  • Co-Diagnostics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4748 holding.
  • Harbour Investments first reported a position in Co-Diagnostics in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's Co-Diagnostics position peaked at $5K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.